Tag : Epidiolex CBD

Politics

DEA Gives CBD Derived Pharmaceutical, Epidiolex, Approval as a Schedule V Drug

Editor
The Drug Enforcement Administration (DEA) has given the Cannabidiol (CBD) derived pharmaceutical product, Epidiolex, a reported Schedule V status. The newly approved drug is an oral solution that is used for the reduction of seizures associated with Lennox-Gastaut syndrome and Dravet syndrome. The CBD product Epidiolex is derived from the cannabis...